← back to search

Alberto Ortega

Universidad Autónoma Metropolitana · MX
Area of research
Molecular Biology · Pharmacology
Research interest
Research interests include Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Drug-Induced Hepatotoxicity and Protection, and Liver Disease Diagnosis and Treatment.
h-index
15
citations
1,385
works
80
NIH funding
primary concept
email

Recent publications

Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
Journal of Hepatology 2022cited by 168position: middledoi
Comprehensive <i>in Vitro</i> Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology
ACS Pharmacology & Translational Science 2021cited by 42position: middledoi
Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations
PLoS ONE 2020cited by 59position: middledoi
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Cancer Cell 2018cited by 337position: middledoi
Advances in the development of histone lysine demethylase inhibitors
Current Opinion in Pharmacology 2015cited by 125position: middledoi
KDM1 Histone Lysine Demethylases as Targets for Treatments of Oncological and Neurodegenerative Disease
Epigenomics 2015cited by 84position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tamara Maes · Cornell University5 papers (2015–2021)Cristina Mascaró · Oryzon Genomics (Spain)4 papers (2015–2021)Carlos Buesa · Cornell University4 papers (2015–2021)Michele MP Lufino · Cornell University3 papers (2018–2021)Marc Martinell · Light Prescriptions Innovators (Spain)2 papers (2018–2020)Tim C. P. Somervaille · University of Manchester2 papers (2015–2018)Angels Estiarte · Cornell University2 papers (2018–2020)Serena Lunardi · Oryzon Genomics (Spain)2 papers (2015–2018)Filippo Ciceri · Cornell University2 papers (2015–2018)Nathalie Guibourt · Cornell University2 papers (2018–2020)Matthew C. T. Fyfe · Mission Therapeutics (United Kingdom)2 papers (2018–2020)Núria Valls · Oryzon Genomics (Spain)2 papers (2018–2020)Alvaro Perdones · Cornell University1 papers (2018–2018)Jordi Salas · Cornell University1 papers (2021–2021)A. Rodríguez-Gimeno · Italian Institute of Technology1 papers (2021–2021)Isidró Ferrer · Università Campus Bio-Medico1 papers (2020–2020)Guido Kurz · Cornell University1 papers (2018–2018)Jordi Salas‐Salvadó · Instituto de Salud Carlos III1 papers (2015–2015)Daniel H. Wiseman · University of Manchester1 papers (2018–2018)Ari Melnick · Cornell University1 papers (2018–2018)